Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
24,112,470
-
Share change
-
+1,189,021
-
Total reported value
-
$336,862,755
-
Price per share
-
$13.97
-
Number of holders
-
77
-
Value change
-
+$13,675,287
-
Number of buys
-
41
-
Number of sells
-
38
Institutional Holders of OXFORD IMMUNOTEC GLOBAL PLC - ORD SHS (OXFD) as of Q4 2017
As of 31 Dec 2017,
OXFORD IMMUNOTEC GLOBAL PLC - ORD SHS (OXFD) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,112,470 shares.
The largest 10 holders included
Invesco Ltd., Polar Capital LLP, Redmile Group, LLC, Alyeska Investment Group, L.P., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Consonance Capital Management LP, BlackRock Inc., AXA, PRICE T ROWE ASSOCIATES INC /MD/, and New Leaf Venture Partners, L.L.C..
This page lists
77
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.